© Copyright Nostre Net
Market Overview
Tissues, cell lines, and cells are tested,
characterized, stored, and collected by the cell banking outsourcing industry.
These activities are carried out to aid in the production of biopharmaceuticals
as well as research and development activities, ensuring minimal side effects
and great efficacy. The technique for cell preservation entails initially
proliferating cells, which subsequently multiply into a large number of
identical cells, which are then stored in cryovials for future use. The
production of regenerative medicine is essentially based on the use of cells.
During the projection period of 2021 to 2027, the cell
banking outsourcing market share is estimated to reach USD 9476.9 million,
growing at a CAGR of 15.6%.
Market Trends
During the forecast period, the cell
banking outsourcing market is expected to rise due to an increase in the number
of cell banks around the world. Another factor projected to drive market growth
is the growing number of applications of cell-based products for research and
therapeutics. Furthermore, a jump in the number of start-ups focusing on
cell-based therapeutics and vaccine production is expected to drive market
expansion. Similarly, the growing emphasis on regenerative and customized
medicine is expected to fuel growth in the cell banking outsourcing industry.
Due to well-established healthcare infrastructure, large patient populations, and
significant healthcare expenditures, several key businesses focus on tailoring
products and services to the American and European markets. There are no public
cord blood banks in Africa, and importing cord blood units from other countries
is prohibitively expensive for most patients. With first-to-market advantage,
launching subsidiaries in developing regions can be advantageous.
Furthermore, as the prevalence of
oncology-related diseases and other infectious chronic diseases rises,
cytological R&D, in which cell banking plays a key role, is predicted to
develop. Over the projected period, R&D for commercialization of novel
characterisation and cryopreservation procedures is expected to significantly
boost profitable business potential.
Concerns over sharing of crucial clinical
information discovered during the donor screening process, as well as issues
around the techniques used to get informed permission from potential cord blood
donors, are limiting the expansion of the cell banking outsourcing business.
Competitive Dynamics
The notable players of the market are
CordLife (Singapore), Cleancells (France), Charles River Laboratories (US), BSL
Bioservice (Germany), BioReliance (US), Sartorius (Germany), Covance (US),
LifeCell International Pvt. Ltd. (India), Goodwin Biotechnology Inc. (US),
GlobalStem Inc. (US), Cryo-Cell International Inc. (US), Lonza (Switzerland),
PX’TherapeuticsSA (France), Wuxi Apptec (China), and the SGS Life Sciences
(Switzerland).
Segmental Analysis
The global cell
banking outsourcing market outlook is divided into three categories: bank,
cell, and application.
The market has been classified into three
categories based on bank type: master cell banking, working cell banking, and
viral cell banking. Because of its widespread utility, master cell banking is
expected to have the largest market share in the worldwide cell banking
outsourcing market.
The cell banking outsourcing market has
been divided into stem cell banking and non-stem cell banking based on cell
type. Because of its growing uses in regenerative medicine, the stem cell
banking sector is expected to have the greatest market share in 2021.
Cell bank storage, cell bank preparation,
and bank characterization and testing are the application segments of the cell
banking outsourcing market.
Regional Overview
North America, Europe, Asia-Pacific, and
the rest of the globe are the regions that make up the market.
Because of the greater adoption rates of
novel technologies for the manufacturing of vaccines and therapeutic
antibodies, North America is expected to have the greatest market share in
2021. Furthermore, the presence of various biopharmaceutical businesses in the
region is expected to drive the cell banking outsourcing market in North
America to new heights in the near future. North America is also likely to be a
lucrative market due to the large number of research and development
initiatives related to cytological inquiry for proteomics, genomics, and
medication and vaccine development currently underway in the region. The
growing demand for vaccines and biopharmaceuticals is expected to boost this
region's growth.
The growing prevalence of leukemia in
European countries is likely to drive the region's cell banking outsourcing
industry forward. Furthermore, the region's cell banking outsourcing market is
benefiting from an increase in the number of clinical trials and associations
dedicated to discovering a cure for incurable diseases.
The cell banking outsourcing market in
Asia-Pacific is predicted to develop at the quickest rate because to the
increased prevalence of hematological illnesses, the growth of healthcare
facilities, and growing support for the use of stem cell-based therapies.
Furthermore, the expansion is likely to be fueled by an increase in the number
of favorable government initiatives relating to biotechnology investments. In
addition, continuous research and development for cancer therapy and fertility
preservation helps to fuel demand for cell banking services.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Overview
Cellulite
production has swelled in recent years due to poor nourishment, static
postures, dehydration, inflammation, eating habits, alcohol intake, among other
factors. The MRFR Cellulite
Treatment Market Sizereport
predicts that the market will earn a revenue level of USD 1,086.44 million
at a CAGR of 8.97% by 2027.
Most
corporate employees with cellulite are working on their wellbeing and fitness
to amplify their productivity. Resultantly, many firms are partnering with
clinics and hospitals to help their staff stay healthy.The cellulite treatment market is
motivated by the tremendous influx of female population in metro centers due to
employment as younger employees are more health-conscious and press for a
better physique to avoid medical problems.
The foremost players in the cellulite
treatment market areNubway (China), Zimmer
Aesthetics (Germany), Skinrex Co., Ltd. (South Korea), Cymedics (Germany),
Tanceuticals, LLC. (US), Cynosure, Inc. (US), Inceler Medikal Co. Ltd.
(Turkey), Syneron Medical Inc (US), Hologic Inc. (US), Cutera (US), Beijing
Sincoheren S & T Development Co., Ltd, (China), Candela Medical (US), and
Merz Pharma GmbH & Co. KGaA (Germany).
Segmental
Analysis
The
segmentation of the cellulite treatment market Insightshas been conducted based on cellulite type,
treatment procedure, region, and end use. The cellulite treatment market is
divided into three segments based on end use: specialized dermatological
clinics, hospitals, and ambulatory surgical centers. The cellulite treatment market has been
segmented based on treatment procedures into minimally invasive, non-invasive,
and topical treatment. The cellulite treatment market has been divided into
three segments based on cellulite type: soft cellulite, hard cellulite, san
francisco cellulite treatment and edematous cellulite. The region segment of
the cellulite treatment market includes North America, Asia-Pacific, Europe, and other important regions.
Detailed
Regional Analysis
The
regional assessment of the cellulite treatment market includesNorth America,
Asia-Pacific, Europe, and other important regions. North America will have the
greatest cellulite treatment market share in 2020, owing to well-established
product development research groups, the availability of novel treatment
products, the consumption of unhealthy diets, and the significant desire for
the sculpted figure. The primary players are expanding their operational
facilities across the region, collaborating in collaborations and partnerships,
and launching new products to drive economic interests. Due to the
transformation of healthcare infrastructure, the construction of R&D
facilities, and increased awareness about body contouring and physical
wellness, the Asia-Pacific cellulite treatment market is estimated to be the
fastest regional market.
Competitive
Analysis
The continuation of occasional lockdowns in
numerous regions may cause the market expansion to be hampered if resources
such as labor and supply chains are severely impacted. The global market is
expected to diversify in operational techniques as innovative models for
operation and delivery are implemented. Government assistance is expected to
support worldwide market development in the next years. Due to the return of
COVID cases in many locations, the market may exhibit constrained growth. It is
projected that the emphasis on accumulating reserves of resources to deal with
unexpected crises would impact future market trends. Market developments and
research are expected to generate attractive growth opportunities in the next
years. The reliance on online commerce for sales is expected to increase
significantly during the forecast period, prompting market stakeholders to
invest more in its growth.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The global dental
industry market trends is projected to reach approximately USD 60.37
billion by 2030, at a CAGR of 6.9% from 2022 to 2030. Dentistry, also known as
oral medicine and dental medicine, is a branch of medicine that consists of the
study, diagnosis, prevention, and treatment of diseases, disorders, and
conditions of the oral cavity, normally in the dentition but also the oral
mucosa, and of adjacent and related structures and tissues, mainly in the
maxillofacial area. Though primarily associated with teeth among the general
public, the field of dentistry or dental medicine is not limited to teeth but
also includes other aspects of the craniofacial complex, including the
temporomandibular joint and other supporting anatomical structures, and
lymphatic, vascular, muscular, and nervous systems. The rising healthcare
expenditure has boosted the demand for the dental industry, thereby accelerating
market growth. Rising geriatric population is anticipated to drive the demand
for the dental industry further
Segment Analysis
Global Dental Industry Market based on the product has been
segmented into discipline, consumables, and end user. The global dental
industry market, by discipline, has been segmented into
endodontics, restorative
dentistry, prosthodontics, periodontics, orthodontics, cosmetic
dentistry, oral surgery, maxillofacial surgery. On the basis of
consumables, the market is bifurcated into resin composites, dental
biomaterial, dental aesthetic, endodontic supplies, gingival
retraction material, whitening material, denture
adhesive, dental impression, dental burs, dental syringe. On the
basis of end user, the market is bifurcated into hospitals &
clinics, specialty dental centers, and dental academic and research
institutes.
Key Players
MRFR recognizes the following companies as the Key
Players in the global dental industry market— 3M (US), Allergan plc (US),
Coltene Group (Switzerland), Dentsply Sirona (US), and Henry Schein, Inc (US).
Regional Analysis
Global Dental
Industry Market Report, based on region, has been divided into the
Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas has been segmented into North America and Latin
America, with the North America market further divided into the US and Canada.
The Americas dominated the market in 2019 and is likely to continue to command
during the assessment period. This is due to the rising prevalence of dental
disorders, leading to the high demand for dental procedures and a preventive,
restorative, and surgical device for dental care. Additionally, the growing
older population is also helping in the growth of the dental industry market.
According to the Administration for Community Living, the population aged 65
and above increased from 37.2 million in 2006 to 49.2 million in 2016 in the
Americas. Hence, a large patient pool suffering from tooth decay and a rising
geriatric population are expected to boom the market growth in the Americas.
The European dental industry market has been divided into
Western Europe and Eastern Europe. The Western Europe dental industry market
has further been classified into Germany, France, the UK, Italy, Spain, and the
rest of Western Europe. Europe is the second-largest region in the dental
industry as dental and oral diseases are among the major concerns for Europeans,
which ultimately shows the need for better treatment. Hence, the demand for
dental devices is increasing in the EU region, which is augmenting the growth
of the dental device market. The availability of advanced diagnostic and
therapeutic options is also playing an important role in the growth of this
market. Ongoing research by medical research laboratories and academic
institutes is leading to new developments in the effective cure of dental
disorders.
The dental industry market in Asia-Pacific has been
segmented into China, India, Japan, South Korea, Australia, and the rest of
Asia-Pacific. Asia-Pacific is expected to register the highest market growth
potential over the forecast period due to increased government initiative and
the presence of a large number of pharmaceutical companies focused on dental
treatment. The initiatives taken by the government to support the healthcare
system are also fueling the growth of the regional market. For instance, in
August 2020, the government has announced the national health ID for every
Indian to develop a centralized mechanism to identify every participant in the
National Health Stack uniquely. Furthermore, the increasing disposable income
of middle-class families, which accounts for a large population in Asia, encouraging
more spending on health, is driving the growth of the dental industry market in
the region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Analysis
The surgical
instrument tracking system market share is predicted to grow at 11.5% CAGR
expected to reach USD 503.5 Million between 2022-2030, reveals the new
Market Research Future (MRFR) report. Surgical instrument tracking systems are
incredibly effective systems that assist healthcare providers. It basically
comprises of software, hardware, and service. The specialty of this tracking
system is it can work wonders in enhancing staff productivity, enhancing
patient safety, and decreasing case delays.
Various factors are propelling the surgical instrument
tracking system market growth. Some of these factors include growing need for
better patient care and inventory management, unique device identification
regulations by FDA, growing prevalence of retained surgical instrument,
increasing number of surgeries, growing need for inventory management, growing
use of medical devices, growth of surgical instruments, and investments by
public and private hospitals, and technological advancements.
On the flip side, the unreliability of barcode systems,
lengthy investment cycles, budgetary limitations, and huge system costs are
factors that may hamper the surgical instrument tracking system market growth
over the forecast period.
Regional Analysis
Based on the region, the surgical instrument tracking system
market report covers the latest trends and growth opportunities across North
America, Europe, the Middle East and Africa, and the Asia Pacific. Of these,
North America will have the lion’s share in the market over the forecast period
chiefly due to the increasing adoption of surgical instrument tracking systems,
highly developed healthcare infrastructure, accessibility of advanced products,
and the UDI regulations by the FDA. The US is the chief contributor in the
region.
The surgical instrument tracking system market in Europe is
predicted to have the second-largest share in the market over the forecast
period. This is chiefly on account of growing private funds, government
initiatives, the emergence of better and high-quality healthcare
infrastructure, cost advantage, rising healthcare sector privatization, and rising
medical tourism.
The surgical instrument tracking system market in the APAC
region is predicted to grow at the fastest pace over the forecast period.
Factors aiding the growth of the surgical instrument tracking system market in
the region include rapidly evolving healthcare infrastructure, increasing
geriatric population, healthcare industry from other regions shifting to APAC,
and better health management. China, as well as India, are the leading
contributors in this region.
The surgical instrument tracking system market in the MEA is
predicted to have a small share in the market over the forecast period.
Market Segmentation
The Market Research Future report provides a complete
segmental analysis of the surgical
instrument tracking system market outlook based on types, end users, and
component.
Based on type, the surgical instrument tracking system
market is segmented into radio frequency identification, barcode tracking,
electronic tracking, and others. Of these, the barcode tracking segment will
have the largest share in the market over the forecast period. It is the most
extensively used, especially in the medical devices industry, which is adding
to the growth of the segment.
Based on end users, the surgical instrument tracking system
market is segmented into laboratories, research facilities, clinics, hospitals,
and others. Of these, the hospitals segment will dominate the market over the
forecast period. This is owing to the high inflow of patients in hospitals
compared to others. Moreover, hospitals use more instruments and equipment and
perform a higher number of surgical procedures compared to other forms of
healthcare providers.
Based on the component, the surgical instrument tracking
system market is segmented into services, software, and others. Of these, the
software segment will lead the market over the forecast period owing to the
introduction of new software applications and frequent need for upgrades.
Key Players
Major players profiled in the surgical instrument tracking
system market report include Key Surgical (US), Mobile Aspects, Inc. (US), TGX
Medical Systems (US), Infor (US), STANLEY Healthcare (US), Censis Technologies,
Inc. (US), B. Braun Melsungen AG (Germany), Dickinson and Company (US), and
Becton. Key players have incorporated different strategies to create a foothold
in the market, such as partnerships/joint ventures, R&D activities, mergers
and acquisitions, product innovations, and more.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Highlights
According to MRFR analysis, the Global Life
Sciences BPO Market share, is expecting to grow at a CAGR of 13.60% and by
the end of the period in 2027, the market is expected to reach a final market
value worth USD 427.78 billion.
Global Life Sciences BPO Market is driven by several
factors, such as rising need for drug research, clinical data management
trials, increasing cost of drug development, new product launches and
government initiatives, increased pressure from regulatory agencies to adopt
various techniques to minimize the costs involved for the successful
introduction of a drug in the market.
A lot of market players are dominating the global life
sciences BPO market. The prominent players are involved in strategic
agreements, product launches, and joint ventures to sustain their market
positions. For instance, in June 2018, Laboratory Corporation of America
Holdings (US) acquired Sciformix Corporation, a Covance company (US), to offer
pharmacovigilance and regulatory solutions to biopharmaceutical and medical
device companies.
Regional Analysis
On a regional basis, the Americas is anticipated to dominate
the global life sciences BPO market, owing to the factors such as
well-established healthcare sector, presence of ample biotechnology and
pharmaceutical companies, new technological advancements in life sciences
industry, major giants in the market involved in merger & acquisition, and
new product innovation. Technologies such as Artificial Intelligence (AI),
Machine Learning (ML) are playing a significant role in the life science BPO
industry, while significantly reducing costs involved with mapping highly
complex studies. Companies are adopting these technologies for drug discovery.
For instance, in June 2019, Navitas Life Sciences (US) in partnership with
ThoughtSphere (US) Company adopted AI and ML technologies to deliver
unparalleled data collection.
On the other hand, Europe is expected to hold the
second-largest position in the global life sciences BPO market, due to the
favorable regulatory scenario to support the outsourcing process in the life
sciences industry. For instance, in 2020, UK Medicines and Healthcare products Regulatory
Agency (MHRA) and the European Medicines Agency (EMA) issued guidance on how
investigators and sponsors should manage clinical trials during the outbreak.
Such moves are set to increase the European life science industry.
Asia-Pacific is anticipated to be the fastest-growing region
over the assessment period due to the rising demand for outsourcing in the life
science industry, and the rising importance of safety & security of
products. Initiatives by the government such as the introduction of ICD-10
standards that capture the inpatient procedures has supported the rising
adoption of electronic health records (EHR), electronic laboratory notebook
(ELN) in the life sciences industry. These digital platforms enable the rapid
growth of the back-end payer and provider BPO services, such as claims
processing, claims management, financial and payroll management, and other
administrative services.
Furthermore, the growth of the Middle East & Africa is
attributed to the technological development in the field of medical and
healthcare industry, high penetration of advanced healthcare technologies in
research organizations such as Saudi Arabia and UAE.
Segmentation
Global Life
Sciences BPO Market outlook has been segmented into Service Type, and
Application.
By Service Type, the market has been segregated into
contract research, contract manufacturing, contract sales, and marketing. Growing
focus on core activities by pharmaceutical companies, increasing the cost of
drug development, clinical trial activities, regulatory constraints are
primarily driving the market growth.
Based on the Application, the global life sciences BPO
market has been classified into medical devices and biopharma and
pharmaceuticals. The medical devices segment is expected to be the fastest
growth owing to the increasing number of medical companies opting to outsource
their strategic and non-strategic processes to vendors to improve their return
on investment (ROI), maintain profitability, product quality, and cost, and to
meet capacity constraints. Pharmaceuticals and biopharmaceuticals segment held
the largest segment in the life sciences BPO market owing to the increased
clinical trial of drugs.
Key Players
Some of the Key Players in the Global Life Sciences BPO
Market are Accenture plc (Ireland), Boehringer Ingelheim GmbH (Germany),
Charles River Laboratories International, Inc. (US), Covance, Inc. (US),
Genpact Limited (US), Catalent, Inc. (US), Infosys (India), Health Decisions,
Inc. (US), Anthelio Healthcare Solutions (India), Cognizant Technology
Solutions (US), ProMab Biotechnologies, Inc. (US), Quintiles Transnational
Corporation (US), Paraxel International Corporation (US), Lonza Group
(Switzerland).
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Highlights
The hydroxychloroquine drug is used in the
treatment of malaria. Apart from malaria, it is also used for the treatment of
rheumatoid arthritis, lupus erythematosus, and recently discovered
COVID-19 disease. Hydroxychloroquine is more preferable than chloroquine as it
has fewer side effects.
The growth of the global hydroxychloroquine
drug market can be contributed to the growing need for rescue medication, high
demand for hydroxychloroquine drugs, due to the outbreak of COVID-19 globally,
and increasing prevalence of chronic diseases.
The Hydroxychloroquine
Market share is anticipated to grow at a CAGR of 28% significantly.
The market value is further expected to increase up to USD 3,784.43 Million in
the studied forecast period 2021-2028. Ipca is the global manufacturer of
hydroxychloroquine drugs. Sanofi S.A., Hikma pharmaceuticals, and Concordia
Healthcare are some of the competitors that dominate the global
hydroxychloroquine market. The key players are involved in awareness campaigns,
product approvals, mergers, and strategic collaborations to strengthen their
market positions. For instance, according to outsourcing-pharma.com, on 19 May
2020, sterling pharma kicks off hydroxychloroquine production. The US FDA
recently lifted import alerts on its plants, paving the way for the firm to
export it to the US. Cadila was already exporting it to the US, though the
numbers were not huge.
Key Players
Some of the key players in
hydroxychloroquine market are Zydus Cadila (India), Ipca laboratories
(India), Sanofi S.A. (France), Hikma Pharmaceuticals (UK), Novartis
International AG (Switzerland), Teva Pharmaceutical, Industries Ltd (Israel), Apotex
Corporation (Canada), Mylan N.V. (US), Concordia Healthcare (UK), Amneal
Pharmaceuticals, Inc. (US), Taj Pharmaceuticals (India), Sun Pharmaceutical
Industries Ltd. (India), Shanghai Pharmaceuticals Holding (China), Hanlim
Pharmaceutical (South Korea), Kyung Poong (South Korea), Laurus Labs Limited
(India), Covis Pharmaceuticals, Inc. (Switzerland), Lupin Pharmaceutical
(India).
Segmentation
The hydroxychloroquine
market outlook has been segmented by strength and application
Based on the strength, the
hydroxychloroquine market has been segmented into 200mg, 400mg, and others.
Among them, 200mg is commonly used to cure arthritis as well as for malaria and
recently for COVID-19. 400 mg dosage is commonly used for the treatment of
Malaria, Lupus Erythematosus, and Rheumatoid Arthritis once a week for the
adults. In addition, the increasing usage of hydroxychloroquine for COVID-19 treatment
is driving the growth of the market.
Based on the application, the segment
is classified into Coronavirus disease (COVID 19), Malaria, Rheumatoid
Arthritis, Lupus Erythematosus, Porphyria cutanea tarda (PCT), Q fever, and
others. The malaria segment dominated the global hydroxychloroquine market and
held the largest market share in 2019. The hydroxychloroquine is used for the
treatment of malaria, which is caused by the mosquito bite. It is a reasonably
inexpensive drug and generally sold as over the counter drug in the countries
such as India.
Regional Analysis
The market has divided into regions like
the Americas, Europe, Asia-Pacific, the Middle East, & Africa. America is
further segmented into North America and Latin America. America does not produce
anti-malarial drugs, as there is no prevalence of malaria. The outbreak of
COVID-19 has increased demand. North America is predicted to be one of the
largest markets for hydroxychloroquine in the coming years. The European
hydroxychloroquine market has been categorized as western Europe and eastern
Europe. Western Europe further classified as Germany, France, the UK, Italy,
Spain, and the rest of western Europe. Asia-Pacific is classified as China,
India, Japan, Australia, South Korea, and the rest of Asia-Pacific. India is
the largest manufacturer of antimalarial drugs. The hydroxychloroquine market
in the Middle East & Africa is categorized into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Highlights
A protective mask acts as a device that
covers the mouth, nose, or both of a patient who requires positive pressure,
non-invasive ventilation, or continuous positive pressure ventilation.
The growth of the healthcare protective
masks market can be attributed to the rise in demand due to the COVID-19
epidemic, rising number of surgical procedures, and increasing prevalence of
infectious diseases.
Healthcare
Protective Masks Market share is expected to reach USD 3,194.5 Million by
2027. It is predicted to grow at a CAGR of 5.7% from 2020 to 2027.Furthermore,
the rising prevalence of age-related diseases, mass manufacturing operations in
Southeast Asian countries, increasing investments in healthcare facilities, and
increasing levels of pollution, are also expected to boost the market during
the forecast period.
However, manufacturers providing
low-quality face masks, and a rise in prices of face masks are expected to
restrain the growth of the healthcare protective masks market.
Several market players such as 3M, Cardinal
Health Inc., and Medline Industries Inc. among others currently dominating the
global healthcare protective masks market.
Key Players
Some of the key players in the global
healthcare protective masks market are 3M (US), Cardinal Health, Inc. (US),
Narang Medical Limited (India), Mölnlycke Health Care AB (Sweden), Henry
Schein, Inc. (US), Medline Industries, Inc. (US), Sterimed (India), Honeywell
International Inc. (US), Kimberly-Clark Corporation (US), Ansell Ltd
(Australia), Dynarex Corp. (US)
Regional Analysis
The market has been divided, by region,
into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The
Americas region held the largest market, owing to the rise in COVID-19 cases in
the region. The healthcare protective masks market in the Americas has further
been branched into North America and Latin America, with the North American
market divided into the US and Canada. The European healthcare protective masks
market has been categorized as Western Europe and Eastern Europe. The Western
European market has further been classified as Germany, France, the UK, Italy,
Spain, and the rest of Western Europe. The healthcare protective masks market
in Asia-Pacific has been segmented into China, India, Japan, Australia, South
Korea, and the rest of Asia-Pacific. Due to the increasing number of surgical
procedures, the market in Asia-Pacific is expected to be the fastest-growing. The
healthcare protective masks market in the Middle East & Africa has been
divided into the Middle East and Africa.
Segmentation
Global Healthcare
Protective Masks Market outlook has been segmented based on the Product
Type and The End User.
Based on the product type, the global
healthcare protective masks have been segmented into surgical masks, anesthesia
masks, and respirators. The surgical masks segment is expected to be the
largest market segment.
On the basis of end user, the market is
segmented into hospitals & clinics, and ambulatory surgical centers. The
ambulatory surgical center segment is expected to be the fastest-growing
segment.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Getting a
different medical opinion is when a patient seeks a medical opinion on their
diagnosis and treatment plan from another, or a few other expert doctors, in
order to confirm the diagnosis and authenticate their treatment. As per MRFR,
the Medical Second Opinionmarket shareis
predicted to gain an income of USD 9751.58 Million at a CAGR of 15.8 % by 2027.
Strong
growth for expert advice due to the COVID 19 outbreak, the financial, health,
and legal costs related to treatment, and the heightened need for better
diagnosis and treatment planning, are projected to propel the medical second
opinion market forward.The COVID 19 outbreak and the increased demand for better diagnosis and
treatment planning are prepared to push the medical second opinion market
forward.
The
renowned payers in the medical second opinion market areCleveland Clinic MyConsult,
Partners Healthcare, HCA Hospitals (US), Teladoc Health, Inc., (US),
SecondOpinionExpert, Inc., (California), DoctorSpring (California), 2nd MD
(Houston), Amradnet (US), Johns Hopkins Medicine, and XMRI.COM.
Competitive
Analysis
The need to establish a quick and
profitable management strategy is predicted to impact the market in the near
future. The market's conflict between demand and supply is investigated to
generate a measured development framework. In the coming future, competitors'
potential to stimulate market transformation will proceed to grow at a steady
rate. Since the market requires an additional drive to achieve consistency in
such a situation, cooperation from administrative authorities and governments
is increasing. The focus on transformation is forecast to expand in the
following years, as user expectations must be addressed more effectively to
recover the global medical second opinion services market. In the subsequent
years, the requirement to ameliorate losses incurred by the current public
health crisis is projected to be the exclusive focus of market applications. In
particular, there will be a need to provide a helping hand to enterprises in
the approaching phase.
Segmental
Analysis
The
segmental overview of the medical second opinion market outlookhas been conducted based on services,
providers, applications, and sources of services. The global medical second
opinion market has been divided into three categories based on services:
post-acute care nursing, medical condition management, and medical peer review
services. The market has been divided into cancer, neurological disorders,
respiratory disorders, a diabetes, cardiac disorders, nd ocular disorders based
on application. The market has been divided into two categories based on the
source of service: in-house and outsourced. The market has been divided into
online physicians' portals, medical second opinion companies, hospital physicians/specialties,
and health insurance companies based on providers.
Detailed
Regional Analysis
Americas
is the largest regional market. The increasing need to improve diagnosis in the
region is expected to drive the market. Moreover, increasing treatment planning
amongst people is also expected to contribute the market growth. The medical
second opinion market in Europe held the second-largest position owing to
increasing medical errors. Asia-Pacific is the fastest-growing segment due to
the developing economy across the region. The medical second opinion is high in
the case of chronic diseases such as diabetes and cancer. The Middle East and
Africa's improving treatment plans and diagnosis with ease of interaction among
patients is expected to boost the second opinion's medical second opinion
market growth.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) expects the nebulizers
market trends to attain a valuation of USD 1,629.7 Million by the year
2027. It is also presumed that the market size will continue to soar at a rate
of 7.32% between 2020 and 2027.
Top
Boosters and Key Barriers
The COVID-19 outbreak has interestingly
been opportune for the nebulizers industry. The rising cases of SARS-CoV-2 have
pushed the demand for albuterol inhalers across hospitals for treating
suspected patients suffering from respiratory issues. COVID-19 is a common
facilitator of asthma or respiratory exacerbations, with the geriatric
population deemed to be more susceptible to these health conditions. This
demography is also highly prone to several respiratory conditions such as
Chronic Obstructive Pulmonary Disease (COPD), novel coronavirus as well as
sleep apnea. In a nutshell, the burgeoning elderly population should foster the
demand for nebulizers market in the upcoming years.
Drug wastage is one of the biggest
challenges faced by the healthcare sector following device usage. Sensing the
opportunity, several companies are coming up with highly innovative nebulizers
such as vibrating mesh, breath-enhanced and breath-actuated nebulizers that cut
down drug wastage and enhance the efficiency of drug delivery. Such nebulizers
help elevate the output rate while reducing the entire administration period.
Besides, the heightened demand for healthcare devices that can be used at home
and the surging consumption of cigarettes, alcohol and tobacco that cause
respiratory disorders should also enhance the market size in the years to come.
Companies
Profiled
Braun Melsungen AG (Germany), Invacare
Corporation (US), Drive DeVilbiss Healthcare (US), Briggs Healthcare (US), GF
Health Products, Inc. (US), PARI (US), Agilent Technologies Inc. (US),
Koninklijke Philips N.V. (Netherlands), OMRON Healthcare (Japan), Vectura Group
PLC (UK), Beurer GmBH (Germany), Rossmax International Ltd (Taiwan), are the
prominent firms in the global market.
Segmental
Status
The nebulizers industry has been dissected
with respect to type, usage, portability along with end user.
The nebulizer types that are available in
the global market are jet, ultrasonic as well as mesh. The types of mesh
nebulizers include passive and active. From the main types of nebulizers, the jet
nebulizers types should procure the top position over the following years since
they are far more cost-effective compared to other types in the market and
should therefore, note higher demand.
Usage-wise, the major segments can be
reusable and disposable. Out of these, the leading spot has been secured by
disposable nebulizers, as these witness significant demand given the provision
of reduced infection rate as well as wastage.
Portable and tabletop are identified as the
main segments, as per portability. The portable nebulizers market has been
progressing at the fastest pace, thanks to its convenient coupled with ease of
use.
Home care, along with hospitals &
clinics are the industry end-users covered in the MRFR study. In light of the
expanding patient base, hospitals and clinics have emerged as the leading
segment in the market. But, it is likely that the homecare segment will achieve
the fastest growth rate in the years ahead.
Regional
Status
Europe/EU, the Americas, Asia Pacific/APAC
and Middle East and Africa/MEA are the key regions across which the nebulizers
market report is expected to note growth over the review period.
The American market has emerged the clear
winner out of the regions, on account of the alarming growth in respiratory
disorders and the favorable reimbursement schemes available in the region. The
region’s performance will be further bolstered by the fact that consumers here
follow a fast-moving lifestyle and therefore, opt for portable devices that are
compact and have multiple advanced features. This scenario is also favored by
the escalating cases of asthma and a number of airway diseases in the region.
The European market stands second and is
expected to attain higher growth in the coming years, in view of the
fast-expanding elderly patient base affected by several respiratory diseases.
Frequent technological advances and the emergence of new and more sophisticated
nebulizers in the market should be favorable as well.
The market size in Asia Pacific is expected
to grow at the fastest pace during the analysis period, largely due to the
rapidly surging cases of respiratory diseases, especially among the massive
geriatric populace. The soaring trend of preventive care, along with surge in
government initiatives to spread awareness among people while also encouraging
technological innovations will benefit the APAC industry over the years to
follow.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Electronic Trial Master File (eTMF)
Systems Market overviewBy Component, Deployment Mode, End User, Region Forecast to 2027. Electronic Trial Master File (eTMF) Systems Market is expected to
reach a value of USD 1825 Million by 2025, at a CAGR of 13.11% during the
assessment period of 2019 to 2025.
Electronic Trial Master File Systems have
grown in favor across a variety of enterprises, including pharmaceutical and
biotechnology firms, in the digital age. The eTMF Systems market is growing in
popularity since the novel solution allows customers to get a real-time view of
clinical papers and manage them effectively. The global eTMF systems market is
growing due to a number of factors, including increased acquisitions, new
solution and service deployments, and partnerships by leading market
participants, as well as an increase in the number of clinical trial studies.
However, small and medium-sized businesses'
budget constraints, as well as a scarcity of experienced people to operate
electronic systems, may make such solutions less appealing. As a result, such
factors may limit the market's expansion throughout the forecast period.
The etmf clinical trials has changed
dramatically as a result of Covid 19. It has heightened the necessity to
integrate digital technologies into therapeutic activities in order to reduce
reliance on manual processes. The epidemic has provided an opportunity to
efficiently and creatively record and maintain clinical trial documents.
Organizations have turned to the eTMF systems idea to combine digitalization
while handling clinical data to capitalize on the new opportunities in the
post-Covid era.
Competitive Dynamics
The notable players of the market are Aurea,
Inc. (US), Covance Inc. (US), ePharmaSolutions (US), MasterControl, Inc. (US),
Oracle (US), Phlexglobal (UK), SureClinical Inc. (US), TransPerfect (US), Veeva
Systems (US), and Wingspan (IQVIA) (US).
Segmental Analysis
The eTMF Systems Market can be divided into
two categories based on their components: software and services. Both market
categories have been performing well, and they are expected to contribute to
the Electronic Trial Master File (eTMF) Systems Market's growth over the
anticipated time.
The eTMF Systems Market can be divided into
on-premise and web/cloud-based systems based on the deployment model. According
to the eTMF Systems Market Forecast, the web/cloud segment will likely be the
fastest-growing segment in the near future.
According on the end-user, the eTMF Systems
Market can be segmented into contract research organizations, biotechnology and
pharmaceutical businesses, and others. Due to the increased demand for exact
master file solutions, contract research companies are likely to acquire a
significant chunk of the Electronic Trial Master File (eTMF) Systems Market
Share throughout the forecasted period.
Regional Overview
The global eTMF
Systems Market research Report is segmented into four regions: the
Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas is
the most important regional sector in terms of market growth on a worldwide
scale. Oracle and Veeva Systems are two key players that control a considerable
percentage of the Electronic Trial Master File (eTMF) Systems Market Value.
On a worldwide scale, the European market
has been performing admirably. The high level of support from regulatory bodies
is one of the market's primary drivers. The adoption of quickly growing
technology in the market is one of the primary Electronic Trial Master File
(eTMF) Systems market trends that is consistent across various regional
sectors.
The Asia Pacific region is expected to
perform well in the market over the anticipated period. Due to the rising
adoption rate of eTMF software and services in Asian countries, the eTMF
systems market in this region is expected to develop at the quickest rate
throughout the assessment period.
The Middle East and Africa regional
division is the smallest in terms of geographical area. The inadequate
development of the region's healthcare infrastructure, as well as a lack of
exposure to digital technologies and innovations, are the key factors for the
eTMF Systems Market's limited growth. Each geographical division is projected
to contribute to global market performance during the forecasted time.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.